Skip to content

艾克美制药

US · ALKS #1780 按市值排名 上市于 1970
41.22 +1.12 +2.79%
实时 - 追踪5344个代码 - 心跳于184秒前 · 2026-10-16 19:53

最新新闻

  • 公司公告
    4: Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.
    SEC · 2026/8/4
  • 公司公告
    4: Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.
    SEC · 2026/6/2
  • 公司公告
    Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.
    SEC · 2026/5/2
  • 公司公告
    4: Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.
    SEC · 2026/7/2
  • 公司公告
    Alkermes | 4: Statement of changes in beneficial ownership of securities-Officer Hopkinson Craig C.
    SEC · 2026/4/2
  • Mizuho Securities Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $65
    \u5e02\u573a\u8d44\u8baf · 2026/9/5
  • A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $38 to $65
    \u5e02\u573a\u8d44\u8baf · 2026/9/22
  • Goldman Sachs Initiates Alkermes(ALKS.US) With Hold Rating, Announces Target Price $50
    \u5e02\u573a\u8d44\u8baf · 2026/9/24
  • 评级变动
    J.P. Morgan Maintains Alkermes(ALKS.US) With Hold Rating, Raises Target Price to $60
    \u5e02\u573a\u8d44\u8baf · 2026/7/13
  • A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $56 to $83
    \u5e02\u573a\u8d44\u8baf · 2026/9/23
  • 评级变动
    Needham Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $62
    \u5e02\u573a\u8d44\u8baf · 2026/7/13
  • 评级变动
    TD Cowen Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $57
    \u5e02\u573a\u8d44\u8baf · 2026/7/13
  • 评级变动
    Piper Sandler Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $65
    \u5e02\u573a\u8d44\u8baf · 2026/8/6
  • 评级变动
    Stifel Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $63
    \u5e02\u573a\u8d44\u8baf · 2026/7/20
  • 评级变动
    Jefferies Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $78
    \u5e02\u573a\u8d44\u8baf · 2026/9/17
  • 评级变动
    Piper Sandler Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $65
    \u5e02\u573a\u8d44\u8baf · 2026/7/28
  • 评级变动
    A Quick Look at Today's Ratings for Alkermes(ALKS.US), With a Forecast Between $58 to $65
    \u5e02\u573a\u8d44\u8baf · 2026/7/30
  • Stifel Maintains Alkermes(ALKS.US) With Buy Rating, Maintains Target Price $63
    \u5e02\u573a\u8d44\u8baf · 2026/10/5
  • 评级变动
    Jefferies Maintains Alkermes(ALKS.US) With Buy Rating, Raises Target Price to $65
    \u5e02\u573a\u8d44\u8baf · 2026/7/9

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:53:58 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

艾克美制药 讨论区 0 条评论

发表评论